Their finding was reported in the journal Diabetes.

Diabetes mellitus is a disease caused by lack of insulin secretion from pancreatic cells, or less response to the secreted insulin, which raises the blood glucose levels, and as a result, causes serious disorders. It is said that at least 171 million people worldwide suffer from diabetes mellitus, and its incidence is increasing rapidly. Clarify the mechanisms of insulin secretion is important for the development of diabetes therapy. Here, this research group focused on TRPM2 acting as a body temperature sensor.

TRPM2 is a temperature-sensitive Ca2+-permeable channel and expressed in pancreatic beta-cells. They found that TRPM2-deficient mice have shown the higher blood glucose levels with impaired insulin secretion compared with wild-type mice. Furthermore, TRPM2-deficient pancreatic beta-cells showed smaller intracellular Ca2+ increase and lesser insulin secretion stimulated by glucose and incretin.

Professor Makoto Tominaga and Dr. Kunitoshi Uchida said,"TRPM2 may control insulin secretion levels mainly by modulating intracellular Ca²⁺ concentrations. Finding the substance which stimulates TRPM2 effectively could lead to the development of a new therapy for diabetes mellitus."

This result is based on a collaborative research with Professor Minokoshi, Division of Endocrinology and Metabolism (NIPS), Professor Yada, Division of Integrative Physiolosy Department of Physiology (Jichi Medical University), and Professor Mori, Graduate School of Engineering (Kyoto University).

Note: If no author is given, the source is cited instead.

• Diabetes
• Hormone Disorders
• Hypertension
• Pancreatic Cancer
• Medical Devices
• Immune System

• Blood sugar
• Diabetes mellitus type 2
• Diabetes mellitus type 1
• Hyperglycemia
• Diabetic diet
• Glycogen